Comparing Jublia vs Tavaborole Topical
Jublia (efinaconazole) | Tavaborole topical |
|
---|
Jublia (efinaconazole) | Tavaborole topical |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Onychomycosis - Toenail. Jublia may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Onychomycosis - Toenail. Tavaborole topical may also be used for purposes not listed in this medication guide. |
Related suggestions Onychomycosis, Toenail
Popular comparisons
|
|||||||
More about Jublia (efinaconazole) | More about Tavaborole topical | ||||||||
Ratings & Reviews | |||||||||
Jublia has an average rating of 5.7 out of 10 from a total of 229 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 41% reported a negative effect. |
Tavaborole topical has an average rating of 4.7 out of 10 from a total of 34 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 53% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Jublia side effects |
View all Tavaborole topical side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Jublia prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Kerydin | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
29.9 hours |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
First Approval Date | |||||||||
June 06, 2014 |
July 07, 2014 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.